Since inception, we have sought to apply our small molecule nucleic acid hybrid chemistry platform toward the discovery and development of novel drugs. The work has culminated in inarigivir, which is now being studied in Phase 2 clinical trials $SBPH: https://bit.ly/341IbG5 pic.twitter.com/WSou9NjdUO
06:30 - 18. stu 2019.
0 replies
0 proslijeđenih tweetova
7 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.